Healthcare -
Biotechnology - NASDAQ - US
$ 46.52
-0.853 %
$ 1.78 B
Market Cap
-12.41
P/E
TARS - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities TARS - Tarsus Pharmaceuticals, Inc.
130 M
LAST VALUE
7773.28%
2 YEAR CAGR
105.36%
5 YEAR CAGR
0.00%
10 YEAR CAGR